ArticleHaematologica2024

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease.

Sabine Kayser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.